Emkay has a hold rating on the stock, Axis Capital has maintained reduce rating, Motilal Oswal is neutral on the stock and Morgan Stanley has retained equal-weight rating. Sharekhan and Edelweiss have a buy rating.
Related Posts
Four reasons why pharma stocks could fall out of favour as Covid recedes
The sector that had peaked out on the bourses in 2015 saw buying interest due to the focus…
February 23, 2021
Why analysts are bullish on this midcap realty stock
Analysts expect the company’s net sales to more than double in FY22 to Rs 2,100 crore over FY21…
March 11, 2021
ARK’s Red-Hot ETF Fell 20% in 12 Days. The Pain for Tech Stocks Might Just Be Beginning.
Invest in Best Mining Pool Invest in Bitcoin Now How to invest in crypto?
March 4, 2021
India brings UAE FPIs on par with Mauritius, Singapore
Move to make it easier for offshore fund managers trading on Indian exchanges to set up shop in…
February 11, 2021